By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Nabi Biopharmaceuticals 

Corporate Headquarters-Research and Development Facility
12276 Wilkins Avenue
Rockville  Maryland  20852  U.S.A.
Phone: 301-770-3099 Fax: 301-770-3097


Company News
Nabi Biopharmaceuticals (NABI) Announces Third Quarter 2012 Financial Results 11/9/2012 10:00:18 AM
Nabi Biopharmaceuticals (NABI) Effects Reverse Stock Split and Announces the Completion of and Final Exchange Ratio for the Business Combination Transaction With Biota Holdings Limited (BTA.AX) 11/9/2012 9:51:12 AM
Nabi Biopharmaceuticals (NABI) Announces Special Cash Dividend 11/5/2012 9:27:04 AM
The Board of Nabi Biopharmaceuticals (NABI) Establishes Ratio for Reverse Stock Split 10/26/2012 6:36:19 AM
Nabi Biopharmaceuticals (NABI) Announces Nabi Stockholder Meeting Results and the Approval of the Business Combination Transaction by Biota Holdings Limited (BTA.AX) Stockholders 10/24/2012 8:45:26 AM
Biota Holdings Limited (BTA.AX) Announces Approval of Definitive Merger Agreement by Nabi Biopharmaceuticals (NABI) Shareholders 10/23/2012 8:46:40 AM
Nabi Biopharmaceuticals (NABI) Announces Exchange Ratio for Proposed Business Combination Transaction With Biota Holdings Limited (BTA.AX) 10/19/2012 8:46:51 AM
Nabi Biopharmaceuticals (NABI) Announces Results of NicVAX® Phase II Study in Combination With Varenicline 10/17/2012 9:37:10 AM
Two Major Independent Proxy Advisory Firms Recommend Nabi Biopharmaceuticals (NABI) Stockholders Support Amended Transaction With Biota Holdings Limited (BTA.AX) at October 22nd Reconvened Special Meeting 10/16/2012 9:39:17 AM
Nabi Biopharmaceuticals (NABI) Announces Adjournment of Special Meeting of Stockholders Until October 22, 2012 9/25/2012 9:36:19 AM